Piper Sandler Maintains Overweight on Evofem Biosciences
Piper Sandler analyst David Amsellem maintains Evofem Biosciences (NASDAQ:EVFM) with a Overweight.
66 Biggest Movers From Friday
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.
Mid-Afternoon Market Update: Dow Dips Over 500 Points; Ross Stores Shares Slide
U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping more than 500 points on Friday.
Mid-Day Market Update: Dow Tumbles 200 Points; TherapeuticsMD Shares Jump
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 200 points on Friday.
Why Evofem Biosciences Shares Are Getting Hammered Today
Evofem Biosciences Inc (NASDAQ: EVFM) shares are trading lower by 59.76% at $0.44 after the company announced the pricing of a roughly $26.6 million public offering.
Evofem Biosciences Announces Pricing of ~$26.6M Public Offering
Evofem Biosciences, Inc. (NASDAQ:EVFM) (Evofem) today announced the pricing of its previously announced underwritten public offering of 22,665,000 shares of its common stock, 12,835,000 pre-funded warrants to purchase
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn’s Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
Here's a roundup of top developments in the biotech space over the last 24 hours:
The Daily Biotech Pulse: Limited Use Of JNJ’s COVID-19 Shot, Myovant-Pfizer’s Relugolix Application Delayed, Gain Therapeutics’ Parkinson’s Data
Here's a roundup of top developments in the biotech space over the last 24 hours.